Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2026
Employees
5,730
Stocks News & Analysis
stocks
The trillion-dollar club: Are these mega-sized stocks still buys?
stocks
New pricing model for embattled ASX tech leader
stocks
Chart of the Week: We see opportunity in Mineral Resources despite debt concerns
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,926.10 | 19.30 | 0.22% |
| CAC 40 | 8,124.19 | 2.16 | 0.03% |
| DAX 40 | 24,083.08 | 201.05 | 0.84% |
| Dow JONES (US) | 47,931.85 | 80.91 | 0.17% |
| FTSE 100 | 9,693.79 | 17.08 | -0.18% |
| HKSE | 26,085.08 | 149.18 | 0.58% |
| NASDAQ | 23,594.91 | 89.77 | 0.38% |
| Nikkei 225 | 50,491.87 | 536.55 | -1.05% |
| NZX 50 Index | 13,483.99 | 31.63 | -0.23% |
| S&P 500 | 6,874.64 | 17.52 | 0.26% |
| S&P/ASX 200 | 8,634.60 | 20.50 | 0.24% |
| SSE Composite Index | 3,902.81 | 27.01 | 0.70% |